Cell-Based Non-Invasive Prenatal Testing

RareCyte NIPT Assay: Non-invasive prenatal testing (NIPT) with gentle single cell isolation

Analyze rare circulating fetal cells (CFCs) from blood for non-invasive prenatal testing

Circulating fetal cells (CFCs) can be isolated from maternal blood and fetal aneuploidies, where number variants can be evaluated by genetic analysis for research purposes.

The RareCyte platform enables CFC analysis, including:

  • Enumeration of CFCs in maternal blood
  • Retrieval of individual CFCs for molecular analysis 
  • Retrieval of individual CRCs for next generation sequencing

Fetal Testing that is Uniquely RareCyte

Analysis of extremely rare CFCs from blood requires a method that is sensitive, specific, and reproducible, and provides the depth of information you need.

The RareCyte platform provides all of the above:

  • Sensitivity: Unbiased and highly sensitive target-cell recovery with the AccuCyte® Sample Preparation System
  • Specificity: Capture and staining antibodies for isolation and detection of fetal cells, and visual confirmation protects against false positives
  • Retrieval: Gentle, single cell isolation for detection of sub-chromosomal duplications and deletions

Contact Us

An easy, integrated workflow from sample prep to cell retrieval

Sample CFC imaging

40x CFC images with CFC-specific biomarkers shown in green and red
Representative 40x CFC images with CFC-specific biomarkers shown in green and red.